Teva Pharmaceutical Industries (TEVA) News Today $16.97 -0.09 (-0.55%) Closing price 06/20/2025 03:59 PM EasternExtended Trading$16.98 +0.01 (+0.05%) As of 06/20/2025 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TEVA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Holdings Reduced by QRG Capital Management Inc.QRG Capital Management Inc. lessened its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 12.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 129,430 shares of tJune 20 at 4:11 AM | marketbeat.comTeva Pharmaceutical Industries Ltd: Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-OncologyJune 18 at 6:03 PM | finanznachrichten.deJanney Montgomery Scott LLC Raises Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)Janney Montgomery Scott LLC lifted its stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 39.5% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,079,281 shares of the company's stock after acquiJune 18 at 4:14 AM | marketbeat.comTeva to collaborate with Fosun Pharma for TEV-56278June 17, 2025 | finance.yahoo.comGAMMA Investing LLC Boosts Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)GAMMA Investing LLC grew its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 804.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 67,474 shares of the company's stock after purchasing an additional 60,016June 17, 2025 | marketbeat.comEliyahu Kalif Sells 55,775 Shares of Teva Pharmaceutical Industries Ltd (TEVA)June 16, 2025 | gurufocus.comHandelsbanken Fonder AB Buys Shares of 15,792 Teva Pharmaceutical Industries Limited (NYSE:TEVA)Handelsbanken Fonder AB purchased a new stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 15,792 shares of the company's stock, valued at approximatelyJune 16, 2025 | marketbeat.comBillionaire Stanley Druckenmiller Dumped His Entire Stake in Palantir and Has Piled Into This Suddenly Unstoppable Drug Stock for 3 Straight QuartersJune 16, 2025 | fool.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Receives $24.44 Average Price Target from BrokeragesJune 15, 2025 | americanbankingnews.comHennessy Advisors Inc. Sells 74,500 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Hennessy Advisors Inc. trimmed its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 10.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 652,100 shares of the compJune 14, 2025 | marketbeat.comSG Americas Securities LLC Has $5.19 Million Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)SG Americas Securities LLC lowered its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 19.3% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 337,899 shares of the company's stock after selling 81,061 shares during theJune 13, 2025 | marketbeat.comGreenwood Capital Associates LLC Boosts Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Greenwood Capital Associates LLC increased its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 61.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37June 12, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Consensus Rating of "Buy" from AnalystsTeva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) has been given a consensus recommendation of "Buy" by the ten ratings firms that are covering the stock, MarketBeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation and two have issued a strJune 12, 2025 | marketbeat.comTeva’s Next-Gen Trail Running Sandal Is Not Only Lighter — It’s Cheaper TooJune 11, 2025 | msn.comDuquesne Family Office LLC Buys 5,882,350 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Duquesne Family Office LLC boosted its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 65.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,879,750 shares of the companJune 11, 2025 | marketbeat.comAssenagon Asset Management S.A. Has $91.97 Million Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Assenagon Asset Management S.A. increased its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 416.0% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 5,983,928 shares of the company's stock after acquiriJune 11, 2025 | marketbeat.comTeva Honored With Power of Partnership Award for Global Health ImpactJune 10, 2025 | finance.yahoo.comTeva Pharmaceutical Industries Limited (TEVA) Presents at Goldman Sachs 46th Annual Global Healthcare Conference TranscriptJune 10, 2025 | seekingalpha.comZacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and ViatrisJune 10, 2025 | finance.yahoo.comGoldman Sachs Initiates Coverage of Teva Pharmaceutical Industries Limited - Depositary Receipt () (TEVA) with Buy RecommendationJune 7, 2025 | msn.comGoldman Sachs Bullish On Branded Drug Upside At Teva: What About Viatris?June 7, 2025 | benzinga.comTraders Purchase High Volume of Teva Pharmaceutical Industries Call Options (NYSE:TEVA)Teva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) was the recipient of unusually large options trading activity on Friday. Stock investors acquired 99,010 call options on the stock. This represents an increase of approximately 183% compared to the average volume of 34,985 call options.June 6, 2025 | marketbeat.comThe Goldman Sachs Group Initiates Coverage on Teva Pharmaceutical Industries (NYSE:TEVA)The Goldman Sachs Group initiated coverage on shares of Teva Pharmaceutical Industries in a research note on Friday. They issued a "buy" rating and a $24.00 price objective for the company.June 6, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) EVP Sells $105,626.12 in StockJune 6, 2025 | insidertrades.comMatthew Shields Sells 6,206 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) StockTeva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) EVP Matthew Shields sold 6,206 shares of the stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $17.02, for a total value of $105,626.12. Following the sale, the executive vice president now owns 9,989 shares in the company, valued at approximately $170,012.78. This represents a 38.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.June 5, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (TEVA) Presents at Jefferies Global Healthcare Conference TranscriptJune 5, 2025 | seekingalpha.comTeva Pharmaceutical prices and manages debtJune 4, 2025 | msn.comTeva Announces Pricing and Early Acceptance Results of its Debt Tender OfferJune 3, 2025 | globenewswire.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Short Interest UpdateTeva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) was the recipient of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 38,700,000 shares, a growth of 36.1% from the April 30th total of 28,430,000 shares. Currently, 3.4% of the company's shares are sold short. Based on an average daily volume of 12,300,000 shares, the days-to-cover ratio is presently 3.1 days.June 3, 2025 | marketbeat.comTeva Announces Early Tender Results of its Debt Tender Offer, Increase to Tender Pool Caps and Total Maximum Amount and Election of Early SettlementJune 3, 2025 | globenewswire.comBourgeon Capital Management LLC Has $5.54 Million Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Bourgeon Capital Management LLC lessened its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 45.3% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 360,722 shares of the company's stock after sellingJune 3, 2025 | marketbeat.comZacks Research Has Bearish Forecast for TEVA Q3 EarningsTeva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) - Zacks Research decreased their Q3 2025 earnings per share estimates for Teva Pharmaceutical Industries in a report released on Wednesday, May 28th. Zacks Research analyst R. Department now expects that the company will post earninJune 2, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd: New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025June 1, 2025 | finanznachrichten.de15,048 Shares in Teva Pharmaceutical Industries Limited (NYSE:TEVA) Purchased by Jefferies Financial Group Inc.Jefferies Financial Group Inc. bought a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 15,048 shares of the company's stocJune 1, 2025 | marketbeat.comNew Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care ...May 31, 2025 | gurufocus.comTeva Pharmaceutical Industries Limited (TEVA) Highlights Long-Acting Injectable Advancements for Schizophrenia at 2025 Psych CongressMay 31, 2025 | insidermonkey.comZacks Research Issues Positive Outlook for TEVA EarningsTeva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) - Zacks Research increased their Q2 2025 earnings per share (EPS) estimates for Teva Pharmaceutical Industries in a research report issued to clients and investors on Wednesday, May 28th. Zacks Research analyst R. Department now expMay 31, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Acquired by Centaurus Financial Inc.Centaurus Financial Inc. increased its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 97.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 35,279 shares of the company's sMay 31, 2025 | marketbeat.comSiemens Fonds Invest GmbH Invests $611,000 in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Siemens Fonds Invest GmbH acquired a new stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 27,722 sharesMay 31, 2025 | marketbeat.comNew Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025May 30, 2025 | globenewswire.comTeva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TEV-'749 (olanzapine) to DateMay 30, 2025 | globenewswire.comTeva Pharmaceutical Industries (NYSE:TEVA) Trading Down 4% - Should You Sell?Teva Pharmaceutical Industries (NYSE:TEVA) Shares Down 4% - What's Next?May 30, 2025 | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Stock Rating Upgraded by Truist FinancialTruist Financial raised Teva Pharmaceutical Industries to a "strong-buy" rating in a research report on Tuesday.May 30, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Sold by California State Teachers Retirement SystemCalifornia State Teachers Retirement System cut its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 8.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,241,262 sharesMay 30, 2025 | marketbeat.comTruist Initiates Teva Pharmaceuticals (TEVA) Coverage with Buy, $25 Price TargetMay 29, 2025 | msn.comTruist Securities Initiates Coverage of Teva Pharmaceutical Industries Limited - Depositary Receipt () (TEVA) with Buy RecommendationMay 29, 2025 | msn.comTeva Reaffirms 2027 Targets, Aims for 30% Operating MarginMay 29, 2025 | msn.comTeva Pharmaceutical Industries (NYSE:TEVA) Earns Buy Rating from Analysts at Truist FinancialTruist Financial initiated coverage on Teva Pharmaceutical Industries in a research report on Wednesday. They issued a "buy" rating and a $25.00 price objective for the company.May 29, 2025 | marketbeat.comTeva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy DayMay 29, 2025 | globenewswire.comCapital A Wealth Management LLC Invests $596,000 in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Capital A Wealth Management LLC purchased a new position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 27,033 shMay 28, 2025 | marketbeat.com Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address TEVA Media Mentions By Week TEVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TEVA News Sentiment▼0.810.65▲Average Medical News Sentiment TEVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TEVA Articles This Week▼913▲TEVA Articles Average Week Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TAK News ARGX News ONC News BNTX News SMMT News GMAB News ITCI News RDY News ASND News VTRS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TEVA) was last updated on 6/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
